A 5-period crossover study to evaluate the effect of meal type and timing on migalastat HCl
pharmacokinetics in healthy male and female subjects. Subjects will be randomly assigned to 1
of 5 treatment sequences and will receive each treatment over the course of 5 weekly periods.